Thaxtomin A Synthesis via 4-Nitro-L-Tryptophan Selectivity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for synthesizing thaxtomin A and its analogues face challenges such as low yields, lack of selectivity, and the need for commercially unavailable 4-nitro-L-tryptophan, which is essential for enhancing thaxtomin A production, due to inefficient fermentation processes and the expense of thaxtomin produced through wild Streptomyces species.

Innovation Solution

A method involving the reaction of tryptophan amides with substituted phenylacrylic acids, followed by cyclization using organic bases like potassium hydroxide, to produce thaxtomin analogues, including thaxtomin A, with specific stereo specificity, utilizing pathways that yield 4-nitro-L-tryptophan and (Z)-2-hydroxy-3-(3-hydroxyphenyl)acrylic acid intermediates.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If nitration with nitric acid and acetic acid is used to synthesize 4-nitrotryptophan, then the synthesis can be achieved, but selectivity is poor and numerous reaction products are formed requiring separation procedures

Engineering Contradiction:
Improvesynthesis feasibilityVSAvoidreaction selectivity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent changes the reaction parameters by using different reagents (sodium nitrite and sulfuric acid instead of nitric acid and acetic acid) and controlling reaction conditions (temperature, pH, stoichiometry) to achieve high selectivity for 4-nitrotryptophan synthesis while maintaining ease of manufacture

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent uses an intermediate compound (4-nitrotryptophan) as a key building block that can be synthesized with high selectivity and then used to produce thaxtomin A and its analogs, thereby separating the nitration step from the final product formation and improving overall process selectivity

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of manufacture

If nitrogramines are used as starting material to synthesize 4-nitrotryptophan derivatives, then synthesis can be achieved, but the product is racemic mixture and L-configuration is not obtained

Engineering Contradiction:
Improvesynthesis feasibilityVSAvoidstereochemical purity
Core Design Contradiction:
Ease of manufactureVSManufacturing precision

Solution Approach 1:

The patent performs preliminary action by using L-tryptophan as the starting material which already has the desired L-configuration, and maintains this stereochemistry throughout the synthesis steps to produce optically active 4-nitro-L-tryptophan, avoiding the need for later separation of racemic mixtures

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the synthetic route parameters by selecting different starting materials (L-tryptophan instead of nitrogramines) and reaction conditions that preserve and enhance optical activity, thereby achieving high enantiomeric purity in the final product

Inventive Principle:
Principle #35Parameter changes

3Reliability

If fermentation process is used to produce thaxtomin A, then the compound can be obtained, but yield is low and production is expensive

Engineering Contradiction:
Improveproduct availabilityVSAvoidproduction yield
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent performs preliminary action by adding 4-nitrotryptophan to the fermentation broth before the fermentation process, which serves as a precursor that enhances the production yield of thaxtomin A during fermentation, thereby improving productivity while maintaining product availability

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses 4-nitrotryptophan as an intermediary substance that bridges the gap between chemical synthesis and biological production, allowing the compound to be fed to microorganisms during fermentation to enhance thaxtomin A yield, combining advantages of both chemical and biological approaches

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for the efficient synthesis of thaxtomin A and its analogues with high enantiomeric purity and herbicidal activity comparable to naturally sourced thaxtomin A, overcoming yield and selectivity issues, and providing sufficient quantities for herbicidal uses.

Implementation Method 1

A method involving the reaction of tryptophan amides with substituted phenylacrylic acids, followed by cyclization using organic bases like potassium hydroxide, to produce thaxtomin analogues

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Implementation Method 2

followed by cyclization using organic bases like potassium hydroxide, to produce thaxtomin analogues

Methodology Applied
Scientific EffectCyclization reaction: Chemical Bonding

Data Source

PatentUS8993762B2Total synthesis of thaxtomin A analogues and their intermediates
Publication Date: 2015.03.31 MARRONE BIO INNOVATIONS INC
  • US8993762B2 patent drawing
  • US8993762B2 patent drawing
  • US8993762B2 patent drawing

AI summary

Improved synthetic methods for the production of thaxtomin analogs, particularly thaxtomin A, and intermediates therefore such as substituted tryptophans and in particular, 4-nitro-L-tryptophan, and substituted phenyl acrylic acids are disclosed. Bioassays show that the synthetic thaxtomin A is not significantly different from the natural one in herbicidal activity.